Selling The Skinny
With the threats from compounders and generics mostly contained, we can take a look at the latest piece of GLP-1 news.
Patenting Privation (Part III): Empowering Revenge
Much like America's waistline, a dispute between Eli Lilly and a large compounder called Empower Pharmacy is expanding.
From ‘Vendor’ To ‘Partner’: How LexisNexis Is Deepening Law Firm Relationships
The company is emphasizing ‘white glove service’ in the AI era. Here’s what the initiative is delivering for clients.
Patenting Privation
Considering how these drug giants are patenting privation gives an interesting look at where Mounjaro and Wegovy may be headed, as well as what IP strategies they are following to keep their profits as fat as possible for as long as possible.